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CONSORTIUM PERFORMANCE AGREEMENT  
UNDER THE CGIAR FUND (TF 069018) 
FOR [NAME OF CRP PROPOSAL] 
This Consortium Performance Agreement (the “CPA”) is entered into by and between: 
- the Fund Council of the CGIAR Fund (the “Fund Council”), represented by the 
International Bank for Reconstruction and Development (the “World Bank”), and  
- the International Plant Genetic Resources Institute (operating under the name of 
Bioversity International, hereafter referred to as “Bioversity”), on behalf of the 
Consortium of International Agricultural Research Centers (the “Consortium”)  
(the Consortium together with the Fund Council are collectively referred to as the “Parties”). 
WHEREAS the Parties are entering into this CPA for the CGIAR Research Program (the “CRP”) 
entitled __________ [name of CRP] to be financed in whole or in part by the CGIAR Fund 
(TF No. 069018) (the “CGIAR Fund”);   
WHEREAS on October 28, 2010, the CGIAR Fund was established; 
WHEREAS donors to the CGIAR Fund (each a “Fund Donor”) and the World Bank as trustee (the 
“Trustee”) have entered into Contribution Agreements and Contribution Arrangements for the 
purpose of contributing funds to the CGIAR Fund (the “Contribution Agreements and Arrangements” 
or the “Contribution Agreements or Arrangements,” as the case may be); 
WHEREAS on April 15, 2011 the Parties entered into a Joint Agreement setting out certain terms and 
conditions governing the submission and approval of CRP proposals, the implementation and use of 
funds in resulting CRPs, including, with respect to the Consortium and Centers, the treatment of 
System Costs (the “Joint Agreement”);  
WHEREAS, the World Bank is signing this CPA solely in its capacity as signatory for the Fund 
Council as the Fund Council does not have legal personality, and not in its capacity as Trustee, Fund 
Office or in any other role, except as otherwise provided herein; 
WHEREAS, the Consortium is a contractual joint venture set up among the 15 International 
Agricultural Research Centers supported by the CGIAR under the Agreement establishing the 
Consortium of International Agricultural Research Centers signed on April 29, 2010 and governed by 
the rules of the Constitution annexed to that agreement; 
WHEREAS, pending its formal establishment as an international organization and until it is ready to 
carry out its business in its own name (the “Interim Period”), the Consortium shall draw on the legal 
personality of  Bioversity, a Center which has its international headquarters in Maccarese, Italy and an 
office in Montpellier, France, and which is authorized to enter into agreements and contract 
obligations on behalf of the Consortium under a Memorandum of Understanding between Bioversity 
and the Consortium Board on behalf of the Consortium dated February 23, 2011 (the “Bioversity 
MOU”); and 
WHEREAS a proposal dated ________, which was submitted by the Consortium to the Fund Council 
and attached hereto as Exhibit 1) (the “CRP proposal”), was approved by the Fund Council on 
_________ as recorded in agreed minutes of the Fund Council attached hereto as Exhibit 2 (the “Fund 
Council Approval”);  
NOW THEREFORE, the Parties hereto agree as follows: 
1. Based on the Fund Council Approval and as set forth in the CRP proposal, the amount of 
funds from Window 1 and Window 2 of the CGIAR Fund that may be transferred to the Lead Center 
as part of this CRP is US$ _____________ (or the equivalent thereof) (the Fund Council-Allocated 
Component); the Total Budget for this CRP is US$ _______ (or the equivalent thereof).  The 
Consortium agrees, and shall require the Lead Center for each CRP and, through such Lead Center, 
any other Centers or Partners participating in such CRP to agree, that this amount and any income 
earned thereon (“Investment Income”)  will be used only for the purposes described in the CRP 
proposal and will be governed by the terms and conditions of the Joint Agreement, which is 
incorporated by reference herein, and this CPA. 
2. Following the Effective Date (as defined below), the Trustee shall disburse the Window 1 and 
Window 2 Funds (as defined in the Joint Agreement) to the Lead Center as follows in accordance 
with a proper Payment Request received by the Trustee from the Consortium prior to each such 
disbursement, at all times subject to the availability of funds: 
[insert timing and amounts or refer to the approved CRP proposal] 
It is understood that the Trustee will transfer Window 3 Funds to Centers so designated by Fund 
Donors in Contribution Agreements and Arrangements pursuant to a W3 Transfer Agreement entered 
into by the Trustee and each such Center, and that a portion of such Window 3 Funds may constitute a 
portion of the Window 3 and Bilateral Component, as set out in the attached CRP proposal. 
3. Following disbursement by the Trustee, (i) the Consortium shall have full fiduciary 
responsibility to the Fund Donors and the Fund Council for use of Window 1 and 2 Funds disbursed 
and the implementation of the CRP in accordance with the terms of the Contribution Agreements or 
Arrangements, the governing Fund Use Agreements to which the Consortium is a party, including the 
Joint Agreement, this Consortium Performance Agreement and any relevant W3 Transfer 
Agreements, and (ii) the World Bank in any capacity will have no responsibility to the Fund Donors, 
the Fund Council or otherwise for the Consortium’s handling of the funds from the CGIAR Fund or 
the activities carried out with such funds.  The Consortium shall have no responsibility to supervise or 
monitor use of Window 3 Funds, and Fund Donors shall have no specific rights of recourse with 
respect to Window 3 Funds under this Consortium Performance Agreement, except that in the event a 
Center implementing the CRP fails to use Window 3 Funds for implementation of the SRF or in 
accordance with the Common Operational Framework, (i) the Consortium may take whatever 
corrective actions it considers appropriate and within its purview; and (ii) the Trustee, in its discretion 
or as instructed by Fund Council decisions, may withhold further disbursements from the CGIAR 
Fund to that Center.  In the event questions of interpretation regarding the use of Window 3 Funds 
arise, (i) decisions about what constitutes activities for implementing the SRF shall be made by the 
Consortium in consultation with the Fund Council, and (ii) decisions about compliance with the 
Common Operational Framework shall be made jointly by the Consortium and the Fund Council.  
Nothing in this CPA shall preclude Fund Donors from entering into side agreements with individual 
Centers for use of Window 3 Funds financed by their Contributions.  
4. The Consortium agrees to exercise its fiduciary duties over the use of Window 1 and Window 
2 Funds. 
5. The offices responsible for the Consortium, Fund Council, Fund Office and Trustee for 
coordination of all relevant matters related to the implementation of this CPA, including providing or 
being provided any notice, taking any action and executing any documents required or permitted 
pursuant to this CPA, are, except as may be notified in writing to the other Contact: 
For the Consortium (the “Consortium Contact”): 
Chief Executive OfficerConsortium Office of the CGIAR Centers 
c/o Agropolis International 
Avenue Agropolis 
34394 Montpellier cedex 5 
FRANCE 
Tel: + 33 (0)4 67 04 75 31 
Fax: + 33 (0)4 67 04 75 83 
For the Trustee (the “Trustee Contact”): 
 
Director 
Multilateral Trusteeship and Innovative Financing 
The World Bank 
1818 H Street, NW 
Washington, DC  20433, U.S.A. 
Tel: + 1 202 458 0019  
Fax: + 1 202 614 0249 
 
For the Fund Council (the “Fund Council Contact”) 
 
Chair of the CGIAR Fund Council 
Vice President, Sustainable Development Network 
The World Bank 
1818 H Street, NW 
Washington, DC  20433, U.S.A. 
Tel: + 1 202 458 7405  
Fax: + 1 202 522 7122 
 
For the Fund Office (the “Fund Office Contact”): 
 
Executive Secretary, CGIAR Fund Council and  
Head, CGIAR Fund Office 
The World Bank 
1818 H Street, NW 
Washington, DC 20433, USA 
Tel: +1 202 473 8918 
Fax: +1 202 473 8110 
 
6. The offices responsible for each of the Fund Donors for coordination of any relevant matters 
related to implementation of this CPA, including providing or being provided any notice, taking any 
action or executing any documents required and permitted pursuant to this CPA, are as specified as 
the “Donor Contact” in the respective Contribution Agreements or Arrangements with the Trustee.  
The Fund Office agrees to notify (i) each of the then-current Fund Donors in the event the Consortium 
Contact changes, and (ii) the Consortium Contact in the event any Donor Contact changes or is added 
to the CGIAR Fund.  
7. The Fund Council and the Consortium will be responsible only for performing their 
respective functions specifically set forth in the Joint Agreement and this CPA and will not be subject 
to any other duties or responsibilities, including, without limitation, any duties or obligations that 
might otherwise apply to a fiduciary or trustee under general principles of trust or fiduciary law.  
Nothing in this Consortium Performance Agreement will be considered a waiver of any privileges or 
immunities of the Fund Council, the Fund Donors, the World Bank, the Consortium or Bioversity 
under their respective Articles of Agreement or equivalent documents and any applicable law, all of 
which are expressly reserved. 
8. The Consortium consents to the disclosure of this CPA and related information in accordance 
with the World Bank’s policy on disclosure of information.  This provision will continue in full force 
and effect following completion of all CGIAR Fund disbursements and termination of the 
Contribution Agreement or Arrangement.   
9. This Consortium Performance Agreement may be terminated by either the Fund Council or 
the Consortium upon 180 days prior written notice.  Additionally, in the event the Trustee exercises 
its right of suspension and/or termination under the Contribution Agreements and Arrangements, the 
Trustee shall consult with the Fund Council and the Consortium to determine the subsequent 
measures to be taken with respect to the CGIAR Fund (as provided in the Contribution Agreements 
and Arrangements), and the Consortium shall accordingly agree to suspend activities under or 
terminate, as the case may be, this CPA.  In the event of any such termination, unless the Fund 
Council and the Consortium agree on another course of action, (i) any agreement entered into prior to 
the termination between the Consortium and any consultants and/or other third parties will remain in 
effect and be unaffected by the termination, and (ii) the Consortium  will be entitled to continue to 
request disbursement of amounts from  the Fund Council-Allocated Component in respect of such 
agreements to the extent contemplated in the Fund Council-Allocated Component and necessary to 
fulfill the Consortium’s obligations thereunder as if this CPA had not been terminated.  The 
Consortium shall cause all other amounts from the Fund Council-Allocated Component remaining 
with the Lead Center or other Centers or Partners participating in the CRP after such termination, 
along with Investment Income thereon, to be returned to the Trustee for deposit into the CGIAR Fund 
(or returned to the Fund Donors pro rata to their respective contributions to the CGIAR Fund if the 
CGIAR Fund has been closed).   
10. Except with respect to clauses that by their nature are meant to survive, this CPA shall 
terminate upon the completion of the CRP.  
11. This CPA may be amended only by written statement between the Fund Council and the 
Consortium.  In the event of conflict between this CPA and the Joint Agreement, the Joint Agreement 
shall prevail. 
12. This Consortium Performance Agreement will come into operation on the date of the last duly 
authorized signature provided below (the “Effective Date”).  
13. Once the Consortium has been established with its own legal personality as an international 
organization and is ready to conduct operations in its own name, the Consortium may request 
approval from the Fund Council to transfer the rights and obligations contracted by Bioversity on 
behalf of the Consortium under this CPA to such international organization.  If approved by the Fund 
Council, then such rights and obligations shall transfer to such international organization as of the 
date of such approval or as otherwise specified by the Fund Council, and the Interim Period shall end 
on that date.    Until such date, Bioversity shall have the rights and obligations contracted on behalf of 
the Consortium under this CPA, and shall be responsible for any liabilities incurred on behalf of the 
Consortium under this CPA, notwithstanding any termination of the Bioversity MOU or any 
termination under Section 9 above.  As provided in the Bioversity MOU, any such liability of the 
Consortium or (during the Interim Period) Bioversity shall be paid from the Funds of the Consortium, 
as such term is defined therein, subject to the consent of the Fund Council, and shared jointly and 
severally among all Centers concerned for any liabilities that are greater than the assets held by or on 
behalf of the Consortium. 
THE FUND COUNCIL, 
By the International Bank for Reconstruction and Development, 
 
 
 
_____________________________________________ 
Inger Andersen 
Vice President, Sustainable Development Network 
 
Date____________________________________________ 
THE INTERNATIONAL PLANT GENETIC RESOURCES INSTITUTE, 
on behalf of the Consortium 
 
_____________________________________________ 
Emile Frison 
Director General 
 
Date____________________________________________ 
 
EXHIBIT 1 
[insert the CRP (ie the approved CRP proposal)] 
EXHIBIT 2 
[insert the FC approval minutes] 
 
